High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia.
Eric DurotDamien Roos-WeilAdrien ChauchetJustine DecroocqRoberta Di BlasiThomas GastinneHedi BensaberMorgane CheminantCaroline JacquetStéphanie GuidezFrançois-Xavier GrosEmmanuel BachyArthur CostePascale Cony-MakhoulSteven P TreonAlain Jacques DelmerRan ReshefSteven Le GouillJorge J CastilloHouot RochPublished in: Blood (2024)
Histologic transformation of Waldenström macroglobulinemia (HT-WM) carries a poor prognosis with standard treatments. Here, we report the first series of HT-WM treated with chimeric antigen receptor T cells showing a high efficacy and no unexpected toxicity.